# FDA Inspection 1162748 - Octapharma Plasma, Inc. - February 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/59edc466-93e5-4243-b418-53af4add0150
Source feed: FDA_Inspections

> FDA Inspection 1162748 for Octapharma Plasma, Inc. on February 17, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162748
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2022-02-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1162748 - 2022-02-17](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/bbc75999-f7a4-421d-bb98-b1edf62995ad)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/4e6e2e69-29f7-43cd-a901-e3414d01eac1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d